newsfilter
← Latest News
Business Wire·

CareDx to Report Second Quarter 2025 Financial Results

CareDx, Inc. (NASDAQ:CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and